Prostatic Metastasis of Renal Cell Carcinoma Presented with Elevated Serum Psa Level

Abstract Renal cell carcinoma (RCC) has the capacity to metastasize to almost any place in the body. The most common expected sites for metastases are the lungs, liver, bone, and brain. Metastasis of renal cell cancer in the prostate has been previously reported in 8 cases. Herein, we present a 73-y...

Full description

Saved in:
Bibliographic Details
Published in:Clinical genitourinary cancer 2017
Main Authors: Urkmez, Ahmet, MD, Ozsoy, Emrah, MD, Sahin, Aytac, MD, Koca, Orhan, MD, Ozturk, Metin Ishak, MD
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Urology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Renal cell carcinoma (RCC) has the capacity to metastasize to almost any place in the body. The most common expected sites for metastases are the lungs, liver, bone, and brain. Metastasis of renal cell cancer in the prostate has been previously reported in 8 cases. Herein, we present a 73-year-old male patient who underwent a transrectal ultrasound guided prostate biopsy (TRUS-Bx) because of a higher prostate specific antigen (PSA) level 15 months after a radical nephrectomy with the indication of right renal cancer. On histopathological examination of his TRUS-Bx specimen, incidentally, prostatic metastasis of renal cell carcinoma was detected. Excluding our patient, almost all of these patients had undergone transurethral resection of the prostate (TURP), and histopathological examination revealed incidental metastases of renal cell carcinoma in the prostate. Our patient was diagnosed after histopathological examination of the prostate biopsy specimen, which was performed because of the elevated PSA level (PSA: 18 ng/ml).
ISSN:1558-7673
DOI:10.1016/j.clgc.2017.03.002